Keryx Biopharmaceuticals (NASDAQ:KERX)

Top Analyst Upgrades and Downgrades: Achaogen, Apple, Athenahealth, Crocs, Disney, Finisar, Jabil, Michael Kors, Occidental, Starbucks and More

Stocks were indicated lower on Monday on additional trade concerns between China and the United States, even with OPEC expected to lower oil production. Investors have seen lower upside after ...
Read Full Story »

Walgreens, Starbucks Straggle into Thursday’s 52-Week Low Club

June 28, 2018: Here are four stocks trading with heavy volume among 221 equities making new 52-week lows in Thursday's session. On the NYSE advancers led decliners by about 1.46 ...
Read Full Story »

Akebia and Keryx Combine to Fight Chronic Kidney Disease

Akebia Therapeutics Inc. (NASDAQ: AKBA) and Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) each saw their shares take a dive on Thursday following news that these two companies had agreed upon a ...
Read Full Story »

Keryx Biopharmaceuticals FDA Win Outweighed by Q3 Loss

Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) shares took a big step back on Tuesday after the company announced its third-quarter results and an update from the U.S. Food and Drug Administration ...
Read Full Story »

Top Biopharma Events Coming by the End of 2017

As the markets continue to hit all-time highs, biotech and pharmaceutical companies have been part of these massive gains. There is a very positive sentiment in the health care sector ...
Read Full Story »
hammered

6 Companies That Destroyed Shareholders Last Week

Last week, the Dow Jones Industrial Average broke its six-day losing streak and S&P 500 hit a new record high. Despite all the positive sentiment in the market, quite a few ...
Read Full Story »
buy sell

Top Analyst Upgrades and Downgrades: Barrick Gold, Home Depot, Kroger, Newmont Mining, SolarCity and More

The stock market has hit new highs but the S&P 500 and Dow futures were indicated to open down 0.1% to 0.2% on Tuesday after oil challenged the $40 mark ...
Read Full Story »
automatic inspection machine

Can Keryx Biopharma Bounce Back From This Supply Interruption?

Shares of Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) sank on Monday after the company announced that there will be an interruption in the supply of Auryxia (ferric citrate) tablets due to a ...
Read Full Story »
biotech word cloud

6 Biotechs Seriously on the Move

A few biotech companies made fantastic runs in Thursday’s session. Over the past 52 weeks, biotech and pharmaceutical stocks have been absolutely crushed, with the SPDR S&P Biotech ETF (NYSEMKT: XBI) ...
Read Full Story »
down market

The 52-Week Low Club for Tuesday

September 8, 2015: Here are four stocks trading with heavy volume among 38 equities making new 52-week lows today. GoPro Inc.) dropped about 1.2% on Tuesday to post a new ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Citizens, EOG, Intuit, Keryx, Marathon, Transocean and Many More

Stocks surged higher on Monday after the Dow had a miserable prior week. Yet again we see that investors will buy their favorite stocks on every stock market pullback. 24/7 ...
Read Full Story »
down market

The 52-Week Low Club for Monday

May 4, 2015: Here are four stocks among the 36 equities making new 52-week lows today. Three of the four are repeats from yesterday’s list. PDL BioPharma Inc. (NASDAQ: PDLI) ...
Read Full Story »
Wall Street

Insider Buying Dominates First Full Week of Trading in 2015

Investors saw huge swings in the market for the first week of trading, wild and woolly start to the new year. The steep sell-off at the start of the week ...
Read Full Story »
Wall Street

Insiders Sell High-Profile Stocks as 2014 Trading Comes to an End

It probably would come as no surprise to most stock market watchers that insiders have taken the opportunity this year to take some money off the table during what has ...
Read Full Story »
Biotechnology word cloud

Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015

Biotech stock investing can be a nerve-racking experience for investors, especially if they are focused on the companies that are waiting on some sort of binary event or clinical data ...
Read Full Story »